SC
EVH icon

Schubert & Co’s Evolent Health EVH Stock Holding History

Schubert & Co’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16
Closed -$520 – 525
2023
Q1 		$520 Hold
16
– – ﹤0.01% 1402
2022
Q4 		$449 Sell
16
-15
-48% -$430 ﹤0.01% 1410
2022
Q3 		$1K Buy
31
+10
+48% +$352 ﹤0.01% 1084
2022
Q2 		$1K Buy
21
+15
+250% +$437 ﹤0.01% 1072
2022
Q1 		$0 Buy
6
+5
+500% +$131 ﹤0.01% 1149
2021
Q4 		$0 Buy
+1
New +$29 ﹤0.01% 1083

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Schubert & Co's EVH Position: Q2 2023 in Review

Schubert & Co sold out of Evolent Health (EVH) in Q2 2023, closing a stake of 16 shares — an estimated $520 sold.

Schubert & Co first reported a position in EVH in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 217 funds tracked by Wall St. Rank hold EVH as of Q2 2023.

  • Schubert & Co reported no remaining Evolent Health position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 16 Evolent Health shares in Q2 2023, an estimated $520.
  • Schubert & Co first reported a position in Evolent Health in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Evolent Health position peaked at $1K in Q3 2022.
  • 217 funds tracked by Wall St. Rank held Evolent Health as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.